AlzChem Group AG

  • WKN: A2YNT3
  • ISIN: DE000A2YNT30
  • Land: Deutschland

Nachricht vom 03.04.2019 | 15:51

AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years

DGAP-News: AlzChem Group AG / Key word(s): Personnel

03.04.2019 / 15:51
The issuer is solely responsible for the content of this announcement.


AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years

Trostberg, April 3, 2019 - Ulli Seibel, CEO of AlzChem Group AG, informed the Supervisory Board today that he will leave the company on December 31, 2019 for personal reasons.

Markus Zöllner, Chairman of the Supervisory Board: "In recent years, Mr. Seibel has been instrumental in driving the realignment of AlzChem into a specialty chemicals company, including the associated investment program. We would like to express our sincere thanks to him for this. We therefore regret all the more Mr. Seibel's resignation at the end of the year."

Ulli Seibel: "After ten exciting and successful years at the helm of AlzChem, it is time for me to pass on the baton. I will continue to be fully committed until the end of the year and ensure a smooth transition so that AlzChem Group AG can continue its growth course without interruption."

About AlzChem
AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,560 employees at four sites in Germany and three other sites abroad.



03.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Solutiance: Hohe Wachstumsdynamik durch den Ausbau des Plattformgeschäfts erwartet

Im ersten Halbjahr 2020 konnte Solutiance den eingeschlagenen Wachstumskurs fortsetzen und im Rahmen dessen die Gesamtleistung (Umsatz zzgl. Bestandsveränderungen) um rund 75 % auf 0,66 Mio. € (1. HJ 2019: 0,38 Mio. €) erhöhen. Das Unternehmen erwartet für das Gesamtjahr durch den weiteren Ausbau der softwarebasierten Dienstleistungen einen Umsatzsprung im Vergleich zum Vorjahr auf rund 3 Mio. €. Bei einem von uns ermittelten Kursziel von 4,85 € vergeben wir das Rating KAUFEN.

Aktuelle Research-Studie

Formycon AG

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

24. September 2020